Stock screenerAll disclosures →
EDGAR →
CDNA
Conviction 100HealthcareScan · Thu, Sep 24, 2026CareDx, Inc. (CDNA) closed at $61.41 (+13.07%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 77, RS Rating 99, at a 52-week high, +220.8% year to date. Sector: Healthcare · SERVICES-MEDICAL LABORATORIES.
CDNA$61.41+13.07%
ResistanceSupportVol 14Insider sell4
Vol MA14 1.31M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price61.41
Change+13.07%
Gap+1.71%
Rel volume2.74×
Avg volume1.25M
Avg $ vol66.5M
SMA 2052.27
SMA 5047.09
SMA 20027.39
Price vs 50+30.41%
Price vs 200+124.17%
MA stackbullish
50/200 cross—
Supertrendup · 50.29
RSI (14)77
MACD hist0.41
MACD crossbull · 2d
Stoch %K / %D88 / 84
ADX (14)46
+DI / −DI39 / 6
RSI divergence—
MACD divergence—
ATR %4.42%
ADR %4.90%
52w high61.41
52w low14.28
From 52w high+0.00%
Above 52w low+330.04%
New 52w highYes
SqueezeOff
Bollinger width22.48%
%B1.28
Donchian pos89.81%
Donchian high63.08
Donchian low46.69
AVWAP (52w high)59.80
vs AVWAP high+2.70%
AVWAP (52w low)27.74
vs AVWAP low+121.39%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d2.74×
Avg vol (14d)1.31M
Avg vol (20d)1.25M
Avg $ vol (20d)66.5M
Market cap3.18B
RS Rating99 / 99
RS 3m (vs SPY)+116.01%
RS 6m (vs SPY)+222.84%
RS line new highYes
Trend template8/8
Technical rank98.8
1 week+13.14%
1 month+20.89%
3 months+120.50%
6 months+239.66%
1 year+294.41%
YTD+220.85%
P/E-148.78
P/B7.46
P/S8.36
P/FCF79.43
EPS-0.4000
Div yield—
ROE-5.02%
ROA-4.01%
Debt/Eq0.00
Current4.58
EV/EBITDA-177.84
Gross margin21.49%
Net margin-5.62%
Rev growth13.79%
EPS growth-140.64%
Price target54.00
Target upside-12.07%
Analyst ratingBuy
Institutional111.55%
Ent. value2.8B
Revenue131.95M
Net income110.64M
Gross profit26.78M
Free cash flow40M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out51.66M
Employees765
ListedThu, Jul 17, 2014
Free float49.03M
Float %95.3%
Short interest5.83M
Days to cover4.8d
Short volume57.4%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.17 vs $0.06
Last surprise+183.3% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank98.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance54.42
Support44.69
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- CareDx +14% on Fresh $74 Analyst Price TargetTikr · Thu, Sep 24, 2026
- Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology SolutionsYahoo Finance · Thu, Sep 24, 2026
Congress activity
Disclosed STOCK Act trades in CDNA
No recent disclosed trades by Congress in CDNA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CDNA · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kennedy Keith CFO & COO · Common Stock · 2026-09-12 | Tax | 8.22K | $430K | 2026-09-12 | 2026-09-15 |
Meng Jessica Chief Commercial Officer · Common Stock · 2026-09-12 | Tax | 6.69K | $350K | 2026-09-12 | 2026-09-15 |
Bickerstaff George Director · Common Stock · 2026-08-05 | Sell | 20K | $926K | 2026-08-05 | 2026-08-06 |
Hanna John Walter JR President and CEO · Common Stock · 2026-07-16 | Exercise | 118K | $968K | 2026-07-16 | 2026-07-17 |
Hanna John Walter JR President and CEO · Common Stock · 2026-07-16 | Sell | 50K | $1.8M | 2026-07-16 | 2026-07-17 |
Hanna John Walter JR President and CEO · Common Stock · 2026-07-16 | Sell | 68K | $2.7M | 2026-07-16 | 2026-07-17 |
Hanna John Walter JR President and CEO · Employee Stock Option (Right to Buy) · 2026-07-16 | Exercise | 118K | — | 2026-07-16 | 2026-07-17 |
Valantine Hannah Director · Common Stock · 2026-07-16 | Exercise | 7.61K | $156K | 2026-07-16 | 2026-07-17 |
Valantine Hannah Director · Common Stock · 2026-07-16 | Exercise | 16.05K | $228K | 2026-07-16 | 2026-07-17 |
Valantine Hannah Director · Common Stock · 2026-07-16 | Exercise | 5.13K | $41K | 2026-07-16 | 2026-07-17 |
SEC filings
EDGAR filings in CDNA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.